WebOct 27, 2024 · Ipratropium bromide and albuterol sulfate inhalation solution may cause the following serious side effects: Worsening of the narrowing in your airways (bronchospasm). This side effect can be life-threatening and has happened with both of the medicines that are in ipratropium bromide and albuterol sulfate inhalation solution. WebJan 8, 2015 · Ipratropium/albuterol is supplied as a solution for inhalation using a nebulizer and a spray to inhale by mouth. It is usually inhaled 4 times a day. Common side effects of ipratropium/albuterol include respiratory tract infection, headache, cough, and nervousness. Ipratropium/albuterol can also cause blurred vision, drowsiness, and dizziness.
DuoNeb Inhalation: Uses, Side Effects, Interactions, Pictures ... - WebMD
WebMar 30, 2024 · Many people using this medication do not have serious side effects.This medication may raise your blood pressure. Check your blood pressure regularly and tell … WebDuoNeb Side Effects. Generic name: albuterol / ipratropium Medically reviewed by Drugs.com. Recent updated on Injure 6, 2024. Serious side effects; Other side effects; Professional info; Note: This document contains side effect information about albuterol / ipratropium. Some dosage forms publicly on these page may non apply to the brand … dust bowl rust
Nebulizers: An Effective Breathing Treatment The Well by Northwell
WebSep 26, 2024 · Common side effects of albuterol and ipratropium may include: headache; trouble breathing; or cold symptoms such as stuffy nose, sneezing, cough, or sore throat. WebAug 23, 2024 · Additional adverse reactions reported in more than 1% of patients treated with DuoNeb (ipratropium bromide and albuterol sulfate) included constipation and voice alterations. In the clinical trial, there was a 0.3% incidence of possible allergic-type reactions, including skin rash, pruritus, and urticaria. WebOct 9, 2024 · SIDE EFFECTS. Adverse reaction information concerning Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol is derived from two 12-week controlled clinical trials (N=358 for COMBIVENT Inhalation Aerosol) as seen in Table 1. dva hearing test